The purpose of this document is to update the “2014 AHA/ACC/HRS Guideline for the
Management of Patients With Atrial Fibrillation” S1. 3-1 (2014 AF Guideline) in areas for …

Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines
Committee provides periodic reviews of new data to produce focused updates that address …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Background Edoxaban, an oral factor Xa inhibitor, is non-inferior for prevention of stroke and
systemic embolism in patients with atrial fibrillation and is associated with less bleeding than …

Aim The primary objective was to compare apixaban to heparin/vitamin K antagonist (VKA)
in patients with atrial fibrillation (AF) and≤ 48 h anticoagulation prior to randomization …

Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a
rhythm control strategy is pursued. We sought to summarize the current evidence on this …

Acute atrial fibrillation is defined as atrial fibrillation detected in the setting of acute care or
acute illness; atrial fibrillation may be detected or managed for the first time during acute …

Background Intracardiac thrombi arising in the left atrial appendage (LAA) are the principal
cause of stroke in nonvalvular atrial fibrillation (AF). Predicting the presence of LAA thrombi …

Electrophysiological and interventional procedures have been increasingly used to reduce
morbidity and mortality in patients experiencing cardiovascular diseases. Although …